629 related articles for article (PubMed ID: 2071901)
21. Evaluation of antibody responses in Indian kala-azar by immunoblot.
Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
[TBL] [Abstract][Full Text] [Related]
22. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
23. [Immunodiagnostic findings in patients with kala-azar].
Mannweiler E; Lederer I; Feldmeier H
Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
[TBL] [Abstract][Full Text] [Related]
24. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
25. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
Singh S; Kumari V; Singh N
Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
[TBL] [Abstract][Full Text] [Related]
26. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
Salotra P; Raina A; Negi NS
Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
[TBL] [Abstract][Full Text] [Related]
27. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
[No Abstract] [Full Text] [Related]
28. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar.
Ray R; Ghose AC
Trans R Soc Trop Med Hyg; 1986; 80(6):998. PubMed ID: 3603654
[No Abstract] [Full Text] [Related]
29. Characterization of the glucosyltransferases that assemble the side chains of the Indian Leishmania donovani lipophosphoglycan.
Mahoney AB; Turco SJ
Arch Biochem Biophys; 1999 Dec; 372(2):367-74. PubMed ID: 10600177
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.
Abdallah KA; Nour BY; Schallig HD; Mergani A; Hamid Z; Elkarim AA; Saeed OK; Mohamadani AA
Trop Med Int Health; 2004 Oct; 9(10):1127-31. PubMed ID: 15482407
[TBL] [Abstract][Full Text] [Related]
31. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.
Muazzam N; Rahman KM; Miah RA; Asna SM
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):77-81. PubMed ID: 1303085
[TBL] [Abstract][Full Text] [Related]
32. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous leishmaniasis serodiagnosis by immunoperoxidase assay.
Halevy D; Sarov B; Sarov I; el-On J
Isr J Med Sci; 1990 Sep; 26(9):485-90. PubMed ID: 2228558
[TBL] [Abstract][Full Text] [Related]
34. Species and stage specificity of Leishmania donovani antigens.
White AC; Hanham C
J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
[TBL] [Abstract][Full Text] [Related]
35. [Visceral leishmaniasis contracted in Europe (kala-azar)].
Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
[No Abstract] [Full Text] [Related]
36. Immune complex antigens as a tool in serodiagnosis of kala-azar.
Chakraborti T; Sarkar D; Ghosh DK
Mol Cell Biochem; 2003 Nov; 253(1-2):191-8. PubMed ID: 14619969
[TBL] [Abstract][Full Text] [Related]
37. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera.
Reed SG; Badaro R; Lloyd RM
J Immunol; 1987 Mar; 138(5):1596-601. PubMed ID: 3543131
[TBL] [Abstract][Full Text] [Related]
38. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
Jaffe CL; Rachamim N; Sarfstein R
J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
[TBL] [Abstract][Full Text] [Related]
39. Cloning of a gene encoding the immunodominant surface antigen of Leishmania donovani promastigotes.
Heath S; Chance ML; Hommel M; Crampton JM
Mol Biochem Parasitol; 1987 Apr; 23(3):211-22. PubMed ID: 3600697
[TBL] [Abstract][Full Text] [Related]
40. Serodiagnosis of Indian kala-azar: evaluation of IFA, ELISA and CIEP tests.
Mittal V; Bhatia R; Sehgal S
J Commun Dis; 1991 Jun; 23(2):131-4. PubMed ID: 1940218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
